Stock News & Analysis

Tesla offers transformational upside, while BYD offers a cheaper entry point.

Roblox stock is down more than 40% this year, but its popular video game platform is far from dead.

Palantir is often criticized by skeptics of being a consulting firm and not a software-as-a-service company.

This beaten-down fintech stock appears undervalued relative to its growth prospects.

GM's revenue lead persists across all eight quarters, yet Tesla's growth volatility and recent acceleration raise questions about the widening gap's durability.

These all have attractive yields and long track records of reliability.

Nvidia has a good problem on its hands: what to do with all this excess capital.

SCHF's lower costs and higher dividend yield make it attractive for cost-conscious investors seeking developed market exposure.

They are both profiting from the AI boom, but one of them looks more attractive right now.

On Oct. 8, 2026, rising Treasury yields and higher oil prices weigh on equities as investors reassess rate expectations.

That massive spending plan could be justified by rapidly growing revenue, but the AI lab has little room for error.

BioNTech's cancer pipeline is bigger than its COVID-era reputation suggests, and the stock still trades below $100.

The medical device giant deserves a lot more attention.

Two tech titans are folding AI into the products billions already use, and that's exactly what makes them built to last.

Nebius and CoreWeave are growing at incredible rates.

Does Chainlink's CCIP 2.0 upgrade matter for LINK holders? It could, but the big banks need to show up first.

Eli Lilly's obesity lead is only the starting point. See what its pipeline, manufacturing build-out, pricing pressure, and earnings trajectory could mean for the stock's next chapter.

This popular valuation metric is essentially at its highest level ever.

There are good reasons not to jump on board with quantum computing stocks just yet.

Tariff refunds lift Helen of Troy stock to an earnings beat.